Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs as demand for complex therapies grows. The contract development and manufacturing organization, which became independent in 2023, is investing heavily in facilities in the U.S. and Germany. At its Bloomington, Indiana site, Simtra has added a flexible clinical line for prefilled syringes and vials and is constructing a new plant with three isolator-based commercial fillin...